Ropes & Gray represented GHO Capital portfolio company Velocity Clinical Research on the deal. GHO Capital portfolio company Velocity Clinical Research announced the acquisition of Meridian Clinical...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Cambrex on the deal. Cambrex, a global contract development manufacturing organization (CDMO) providing products and services across the entire drug lifecycle, signed a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Avista Capital Partners in the transaction. Avista Capital Partners executed its acquisition of Taconic Biosciences, a provider of genetically engineered research models...
You must be a Standard 1 Year member to access this content.
WilmerHale advised PTC Therapeutics, while Ropes & Gray advised Blackstone on the deal. Blackstone announced a strategic financing collaboration for up to $1 billion in funding...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised H.I.G. Capital on the deal. Latham & Watkins represented the private credit providers to H.I.G. Jones Day advised Avient Corporation. H.I.G. Capital...
You must be a Standard 1 Year member to access this content.
Gibson, Dunn & Crutcher LLP advised Hahn & Company, while Ropes & Gray advised Coller Capital and Hahn & Company on the transaction. South Korean private...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised 3i Group plc on the deal. Mishcon de Reya has advised the management team at Digital Barriers. 3i Group plc announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised GHO Capital Partners and Genesis Research in the transaction. Macfarlanes advised Market Access Transformation. Genesis Research announced the acquisition of Market Access...
You must be a Standard 1 Year member to access this content.
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison represented Aptiv, while Ropes & Gray represented TPG Capital and its portfolio company Wind River in the transaction. Aptiv executed...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Galderma on the deal, while Latham & Watkins advised ALASTIN. Galderma, one of the world’s largest independent dermatology companies, executed its acquisition...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Arbor Biotechnologies on the deal. Arbor Biotechnologies announced an oversubscribed and up-sized $215 million Series B financing. Arbor plans to use the...
You must be a Standard 1 Year member to access this content.
